Protagonist Therapeutics (PTGX) Other Non Operating Income (2017 - 2025)
Historic Other Non Operating Income for Protagonist Therapeutics (PTGX) over the last 8 years, with Q3 2025 value amounting to $33000.0.
- Protagonist Therapeutics' Other Non Operating Income fell 7659.57% to $33000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $182000.0, marking a year-over-year decrease of 3079.85%. This contributed to the annual value of $250000.0 for FY2024, which is 22437.81% up from last year.
- Protagonist Therapeutics' Other Non Operating Income amounted to $33000.0 in Q3 2025, which was down 7659.57% from $36000.0 recorded in Q2 2025.
- Over the past 5 years, Protagonist Therapeutics' Other Non Operating Income peaked at $141000.0 during Q3 2024, and registered a low of -$195000.0 during Q1 2023.
- In the last 5 years, Protagonist Therapeutics' Other Non Operating Income had a median value of $0.0 in 2021 and averaged -$1611.1.
- In the last 5 years, Protagonist Therapeutics' Other Non Operating Income soared by 64615.38% in 2022 and then plummeted by 160000.0% in 2023.
- Protagonist Therapeutics' Other Non Operating Income (Quarter) stood at -$13000.0 in 2021, then soared by 646.15% to $71000.0 in 2022, then tumbled by 38.03% to $44000.0 in 2023, then dropped by 29.55% to $31000.0 in 2024, then grew by 6.45% to $33000.0 in 2025.
- Its Other Non Operating Income stands at $33000.0 for Q3 2025, versus $36000.0 for Q2 2025 and $82000.0 for Q1 2025.